Curadis Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Curadis General Information

Description

Developer of therapeutic drugs intended to focus on the treatment of cancer. The company's drugs are engaged in developing of novel drugs and therapeutic concepts for the treatment of hormone-dependent diseases and cancers, enabling patients to recover from various critical diseases.

Contact Information

Website
www.curadis.eu
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Henkestraße 91
  • 91052 Erlangen
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Henkestraße 91
  • 91052 Erlangen
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curadis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Jun-2019 Completed Out of Business
3. Later Stage VC 01-Jul-2016 Completed Generating Revenue
2. Early Stage VC 08-Dec-2010 Completed Generating Revenue
1. Seed Round 01-Jan-2008 Completed Generating Revenue
To view Curadis’s complete valuation and funding history, request access »

Curadis Patents

  • 56

    Total Documents Applications and Grants

  • Total Patents Families

  • 27

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Curadis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019352068-A1 Combinations with a c-19 steroid for treating cancers Active 04-Oct-2018
AU-2019352068-B2 Combinations with a c-19 steroid for treating cancers Inactive 04-Oct-2018
AU-2019352068-B9 Combinations with a c-19 steroid for treating cancers Inactive 04-Oct-2018
CA-3112891-A1 Combinations with a c-19 steroid for treating cancers Pending 04-Oct-2018
EP-3632445-A1 Combinations with a c-19 steroid for treating cancers Inactive 04-Oct-2018 A61K31/568
To view Curadis’s complete patent history, request access »

Curadis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Curadis FAQs

  • When was Curadis founded?

    Curadis was founded in 2008.

  • Where is Curadis headquartered?

    Curadis is headquartered in Erlangen, Germany.

  • What is the size of Curadis?

    Curadis has 2 total employees.

  • What industry is Curadis in?

    Curadis’s primary industry is Drug Discovery.

  • Is Curadis a private or public company?

    Curadis is a Private company.

  • What is Curadis’s current revenue?

    The current revenue for Curadis is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process